- Intravenous Tenecteplase for Acute Ischemic Stroke Within 4.5–24 Hours of Onset (ROSE-TNK): A Phase 2, Randomized, Multicenter Study
-
Wang L, Dai YJ, Cui Y, Zhang H, Jiang CH, Duan YJ, Zhao Y, Feng YF, Geng SM, Zhang ZH, Lu J, Zhang P, Zhao LW, Zhao H, Ma YT, Song CG, Zhang Y, Chen HS
- KMID: 2546438
- J Stroke.
- 2023 Sep;25(3):371-377.
- doi: 10.5853/jos.2023.00668
Background and Purpose Intravenous tenecteplase (TNK) efficacy has not been well demonstrated in acute ischemic stroke (AIS) beyond 4.5 hours after onset. This study aimed to determine the effect of... -
- CITED
-
- Close
- SHARE
-
- Close
